Results 51 to 60 of about 26,689 (268)

Characteristics of lapsed apheresis donors from 2016 to 2020, Zhejiang Blood Center

Zhongguo shuxue zazhi, 2022
Objective To understand the structural characteristics of lapsed apheresis donors in our blood center and provide guidance for further improving recruitment and retention strategies by retrospectively analyzing the characteristics of lapsed apheresis ...
Lijian TAO, Zhongxiu WU, Fuxian KONG, Chunyan LI, Jun YE, Qing FENG   +5 more
doaj   +1 more source

Next‐Generation CAR‐T Cell Therapy: From Modular Design to Clinical Expansion

Exploration, EarlyView.
Over the past decades, chimeric antigen receptor (CAR)‐T cell therapy has evolved from a linear engineering concept into a powerful yet constrained immunotherapy, limited by tumour microenvironment barriers, immune evasion, and manufacturing complexity.
Yuesong Bai, Jintao Qin, Zongjun Dai, Ran Yan, Yong Yang, Wenguang Wang   +5 more
wiley   +1 more source

Assessing Knowledge, Public Awareness, and Confidence Assurance of Apheresis Donors among Blood Bank Donors in Tobruk, Libya.

Tobruk University Journal of Medical Sciences
Background: Blood donation is a critical component of healthcare, and apheresis has emerged as an advanced technique for collecting specific blood components, such as platelets, plasma, and red blood cells. Despite its advantages, apheresis remains less
Alkadafe Agelah, Hanan Mahdi
doaj   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense, Nicole Bavaro, Aashna Farishta, Jiaqi Chen, Raj Chovatiya   +4 more
wiley   +1 more source

Allergen‐Functionalized Microfluidic Immunoadsorption Platform for Selective Depletion of Peanut‐Specific Antibodies From Whole Blood

Journal of Polymer Science, EarlyView.
We present a microfluidic immunoadsorption platform functionalized with a layer‐by‐layer (LbL) nanofilm composed of poly(diallyldimethylammonium chloride) (PDDA) and protein extract (PE) for selective capture of peanut‐specific antibodies directly from the whole blood obtained from a peanut allergy mouse model.
Hesaneh Ahmadi, Nur Hendri Wahyu Firdaus, Rutwik Joshi, Akhilesh Kumar Shakya, Wei Li   +4 more
wiley   +1 more source

Assessing blood donation applicant characteristics to optimize the promotion of apheresis [PDF]

, 2020
For effectively using blood products from a limited donor population, the promotion of apheresis donation should be emphasized more often. This study assessed the demographic data of apheresis applicants using blood donor data from the Japanese Red Cross
KAWAHARA, Kazuo, KUMAZAWA, Daisuke, SUGAWA, Makiko   +2 more
core   +1 more source

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Systemic psoriasis treatment options have rapidly expanded in Japan, including the approval of tyrosine kinase 2 and interleukin‐36 receptor inhibitors in 2022. However, contemporary real‐world treatment patterns across plaque, erythrodermic, and generalized pustular psoriasis remain incompletely characterized.
Yayoi Tada, Yoshiko Maeda, Miyuki Hasegawa, Motonobu Sakaguchi, Takamasa Hashimoto, Teruko Narusawa, Nobuyoshi Takabayashi, Tomoko Takahashi, Taisuke Kondo, Shingo Kuroda   +9 more
wiley   +1 more source

The Italian Registry of Therapeutic Apheresis: Granulocyte_Monocyte Apheresis in the Treatment of Inflammatory Bowel Disease. A Multicentric Study

, 2011
The Italian Registry of Therapeutic Apheresis: Granulocyte-Monocyte Apheresis in the Treatment of Inflammatory Bowel Disease.
Di Leo V, Saladino V, Repaci G, D'Ovidio V, Astegiano M, Valpiani D, Costa F, Santini A, Testa R, Silla M., Lecis P, Aratari A, Guidi ML, Bresci G, RICCI, Chiara, Riegler G, Calella F, Marco M, D'Incà R, Sablich R, Principi M, Colombo E, Armuzzi A, Passalacqua S, Ferraro PM, Cavallaro F   +25 more
core   +1 more source

A Rare Case of Acquired Haemophilia A Following Sigmoid Adenocarcinoma: Case Report and Literature Review

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Acquired haemophilia A (AHA) is a rare complication of malignancy. We report a case of AHA secondary to colorectal cancer which presented as post‐operative bleeding, progressive activated partial thromboplastin time prolongation, precipitous factor VIII (FVIII) decline and inhibitor development.
Benjamin Reardon, Harini Haran, Jennifer Curnow   +2 more
wiley   +1 more source

Urinary Neopterin and Microalbuminuria in Patients Treated by Low-density Lipoprotein Apheresis

Pteridines, 2005
Low-density lipoprotein (LDL)-apheresis is a method of extracorporeal elimination of LDL-cholesterol in patients with severe primary lipoprotein disorders.
Cermanová Melanie, Melichar Bohuslav, Solichová Dagmar, Bláha Milan, Bláha Vladimir, Blazek Martin, Mašín Vladimir, Cerman Jaroslav, Zadák Zdenek   +8 more
doaj   +1 more source